News

European Pharmacopoeia, during its 179th session in June 2024, confirmed the removal of the rabbit pyrogen test- RPT from its monographs. As explained by the European Directorate for the Quality of Medicines- EDQM, the RPT has been the traditional method...

The biopharma industry is well-positioned to respond to upcoming patent expirations by pursuing mergers and acquisitions, according to a research note from Morgan Stanley. The report, dated July 11, states that products losing exclusivity through 2030 generate a combined...

Artificial intelligence- AI is fundamentally reshaping drug discovery in the pharmaceutical industry, offering a sustainable approach to developing new therapies. Traditionally, this process has been resource-intensive, involving costly laboratory experiments and extensive clinical trials. AI promises to accelerate the...

The European Commission has released findings from a pilot study aimed at understanding the difficulties in ensuring secure drug supply chains. According to the commission, obtaining information on critical medical products was highlighted as a major challenge. However, significant...

The European Medicines Agency has set forth its objectives for the Product Management Service (PMS), aiming for it to serve as a definitive repository of medicinal product information. PMS functions as a comprehensive database accessible to regulators and marketing...

Running a clinical study entails significant costs and necessitates collaboration among sponsors, vendors, CROs, and sites to ensure trial success. At the 13th Annual Clinical Trials in Oncology East Coast 2024 conference in Burlington, Massachusetts, panelists discussed the factors influencing...

The market for clinical trial supplies has shown strong growth recently, expanding from $2.52 billion in 2023 to $2.75 billion in 2024, with a compound annual growth rate (CAGR) of 8.9%. This growth in the historical period is attributed...